Members |
targetComponentId |
Fetal or neonatal effect of membranitis |
Fetal disorder due to chorioamnionitis |
Fetal or neonatal effect of membranitis |
Fetal disorder due to chorioamnionitis |
Fetal or neonatal effect of narcotic transmitted via breast milk |
Neonatal disorder caused by narcotic transmitted via breast milk |
Fetal or neonatal effect of narcotic transmitted via placenta |
Fetal disorder caused by narcotic transmitted via placenta (disorder) |
Fetal or neonatal effect of noxious substance transmitted via placenta |
Fetal disorder caused by noxious substance transmitted via placenta (disorder) |
Fetal or neonatal effect of oblique lie before labor |
Fetal disorder due to oblique lie before labour |
Fetal or neonatal effect of oblique lie before labor |
Fetal disorder due to oblique lie before labour |
Fetal or neonatal effect of oligohydramnios |
Fetal disorder due to oligohydramnios (disorder) |
Fetal or neonatal effect of persistent occipito-posterior malposition during labor and delivery |
Fetal disorder due to persistent occipito-posterior malposition during labour |
Fetal or neonatal effect of persistent occipitoposterior position |
Fetal disorder due to persistent occipito-posterior malposition during labour |
Fetal or neonatal effect of placenta previa |
Perinatal disorder due to placenta praevia |
Fetal or neonatal effect of placenta previa |
Perinatal disorder due to placenta praevia |
Fetal or neonatal effect of placental damage caused by cesarean section |
Perinatal disorder due to placental damage due to caesarean section |
Fetal or neonatal effect of placental or breast transfer of alcohol |
Fetal disorder caused by maternal alcohol dependence in pregnancy |
Fetal or neonatal effect of polyhydramnios |
Fetal disorder due to polyhydramnios (disorder) |
Fetal or neonatal effect of prolapsed cord |
Perinatal disorder due to prolapsed cord |
Fetal or neonatal effect of shoulder presentation |
Fetal disorder due to shoulder presentation during labor |
Fetal or neonatal effect of shoulder presentation during labor and delivery |
Fetal disorder due to shoulder presentation during labor |
Fetal or neonatal effect of transverse lie |
Fetal disorder due to transverse lie |
Fetal or neonatal effect of transverse lie before labor |
Fetal disorder due to transverse lie before labor |
Fetal or neonatal effect of transverse lie before labor |
Fetal disorder due to transverse lie before labor |
Fetal or neonatal effect of transverse lie during labor and delivery |
Fetal disorder due to transverse lie during labor |
Fetal or neonatal effect of unstable lie before labor |
Fetal disorder due to unstable lie before labor |
Fetal or neonatal effect of unstable lie before labor |
Fetal disorder due to unstable lie before labor |
Fetal or neonatal effect of vacuum extraction delivery |
Disorder of early neonate and/or fetus during second intrapartum stage due to vacuum extraction delivery |
Fetal or neonatal intraventricular non-traumatic hemorrhage grade 4 |
Non-traumatic intraventricular hemorrhage grade 4 during intrapartum and/or early neonatal period (disorder) |
Fetal or neonatal period |
Fetal and/or neonatal period |
Fetal reduction or destruction procedure |
Destruction of fetus |
Fetishistic transvestism |
Fetishistic transvestism |
Fetoplacental hormones NOS |
Fetoplacental hormone measurement |
Fetoplacental hormones NOS |
Fetoplacental hormone measurement |
Fetus &/or neonate affected by malpresentation (& [before labor]) |
Fetal disorder due to malpresentation during prelabour |
Fetus &/or neonate affected by maternal polyhydramnios |
Fetal disorder due to polyhydramnios (disorder) |
Fetus OR newborn affected by external version before labor |
Fetal disorder due to external version before labor (disorder) |
Fetus OR newborn affected by premature rupture of membranes |
Fetal disorder due to premature rupture of membranes (disorder) |
Fetus OR newborn affected by prolapsed cord |
Perinatal disorder due to prolapsed cord |
Fetus or neonate affected by abnormal uterine contractions (& [hypertonic labor] or [uterine inertia]) |
Fetal disorder due to hypertonic uterine dysfunction (disorder) |
Fetus or neonate affected by chorioamnionitis |
Fetal disorder due to chorioamnionitis |
Fetus or neonate affected by destructive operation to aid delivery (& [destruction of fetus]) |
Fetal disorder due to destructive operation to facilitate delivery (disorder) |
Fetus or neonate affected by malpresentation before labor NOS |
Fetal disorder due to malpresentation during prelabour |
Fetus or neonate affected by other specified malpresentation before labor |
Fetal disorder due to malpresentation during prelabour |
Fetus or neonate affected by unspecified malpresentation before labor |
Fetal disorder due to malpresentation during prelabour |
Fetus or newborn affected by other specified abnormality of amnion, NEC |
Perinatal disorder of fetus and/or neonate due to abnormality of amnion |
Fetus or newborn affected by other specified abnormality of chorion, NEC |
Fetal disorder due to abnormality of chorion (disorder) |
Fetus poison - placenta/breast |
Fetal disorder caused by substance transmitted via placenta |
Fetus poison - placenta/breast |
Fetal disorder caused by substance transmitted via placenta |
Fetus with chromosomal abnormality (& suspect: [CF] or [mongol]) |
Fetal cystic fibrosis suspected |
Fetus with chromosomal abnormality with antenatal problem |
Fetal chromosomal abnormality (disorder) |
Fetus with damage NOS |
Fetal disorder |
Fetus with damage NOS |
Fetal disorder |
Fetus with damage due to intrauterine contraceptive device with antenatal problem |
Fetal damage caused by intrauterine contraceptive device (disorder) |
Fetus with damage due to other maternal disease |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease - delivered |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease NOS |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease unspecified |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease with antenatal problem |
Fetal disorder due to disease in mother (disorder) |
Fetus with drug damage with antenatal problem |
Fetal disorder caused by drug or medicament |
Fetus with hereditary disease NOS |
Fetal hereditary disease |
Fetus with hereditary disease unspecified |
Fetal hereditary disease |
Fetus with hereditary disease with antenatal problem |
Fetal hereditary disease |
Fetus with maternal problem NOS |
Fetal disorder due to disease in mother (disorder) |
Fetus with maternal problem NOS |
Fetal disorder due to disease in mother (disorder) |
Fetus with radiation damage |
Fetal disorder caused by ionising radiation |
Fetus with radiation damage - delivered |
Fetal disorder caused by ionising radiation |
Fetus with radiation damage NOS |
Fetal disorder caused by ionising radiation |
Fetus with radiation damage unspecified |
Fetal disorder caused by ionising radiation |
Fetus with radiation damage with antenatal problem |
Fetal disorder caused by ionising radiation |
Fetus with viral damage via mother with antenatal problem |
Fetal damage due to maternal viral infection (disorder) |
Fexofenadine 30mg/5mL oral suspension |
Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Fexofenadine hydrochloride + pseudoephedrine hydrochloride 60mg/120mg tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride 180mg m/r tablet |
Fexofenadine only product in oral dose form |
Fexofenadine hydrochloride 180mg prolonged-release oral tablet |
Fexofenadine only product in oral dose form |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg m/r tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg prolonged-release oral tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg m/r tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet |
Fexofenadine and pseudoephedrine only product |
Fiancé of subject |
Fiance |
Fiber |
Plant fiber |
Fiberlight anesthetic laryngoscope |
Fibreoptic laryngoscope |
Fiberoptic esophagoscopy NEC |
Endoscopy of esophagus |
Fibreoptic bronchoscopy: [diagnostic NOS] or [NEC] |
Fiberoptic bronchoscopy |
Fibreoptic oesophagoscopy: [diagnostic NOS] or [NEC] |
Endoscopy of esophagus |
Fibrin AND/OR fibrinogen agent |
Coagulation related substance (substance) |
Fibrinolysis - postpartum |
Postpartum disorder of abnormal fibrinolysis (disorder) |
Fibrinolytic system finding |
Disorder involving the fibrinolytic system |
Fibroadenoma, no International Classification of Diseases for Oncology subtype |
Benign fibroadenoma (morphologic abnormality) |
Fibrocalculous pancreatopathy without complication |
Fibrocalculous pancreatic diabetes |
Fibrocystic disease |
Nonproliferative fibrocystic disease |
Fibrohistiocytic neoplasm - category |
Fibrohistiocytic neoplasm (morphologic abnormality) |
Fibroma, no International Classification of Diseases for Oncology subtype |
Benign fibroma |
Fibromyalgia |
Fibromyositis |
Fibrous papule of the nose |
A small, solid lesion, less than 1 cm in diameter, raised above the surface of the surrounding skin and hence palpable |
Fibula X-ray |
Plain X-ray of fibula (procedure) |
Fifth day fits |
A type of self-limited focal epilepsy with onset typically between day two and seven of life. Seizures are focal tonic at onset, affecting the head, face, and limbs. Focal clonic or tonic seizures may evolve to bilateral tonic or clonic seizures. Onset may alternate between hemispheres. Autonomic features (apnea and cyanosis) are present in one third of seizures and may be the predominant manifestation. Seizure semiology may progress in a sequential pattern with tonic, clonic, myoclonic and autonomic features following each other without a single predominant feature. Clusters of seizures may occur over hours or days with the neonate behaving normally between events. Developmental progress is usually normal. The electroencephalogram (EEG) background is normal or has minor nonspecific abnormalities. Focal interictal epileptiform abnormalities can be seen in the central, centrotemporal or frontotemporal regions. MRI is normal or has nonspecific findings. Pathogenic variants are seen in KCNQ2, KCNQ3 and SCN2A. |
Fifth ventricle |
Structure of cave of septum pellucidum (body structure) |
Filaricides |
Anthelmintic |
File root canal |
Root canal preparation |
Filgrastim 30million units/mL injection solution 1mL vial |
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Filgrastim 48million units/mL injection solution 1.6mL vial |
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Film production NOS |
Motion picture producer |
Film production NOS |
Motion picture producer |